Poongjeon Pharmacy: Rights offering (paid-in capital increase) decision
This is a major matters report in which a company announces its board has decided to raise money by issuing new shares for cash, which can include offering them to existing shareholders or others. It usually tells shareholders that the share count may increase, which can dilute their ownership, and the filing itself would set out the size, pricing and purpose, which were not provided here. Poongjeon Pharmacy filed this on Oct 26, 2026.
Predicted impact: Medium
₩3B rights offering decision, about 14% of market value; repeats the earlier allotment item.
Company filing